ConvaTec Group (CNVVY) to Release Earnings on Wednesday

ConvaTec Group (OTCMKTS:CNVVY) is expected to be announcing its results before the market opens on Wednesday, February 25th. Analysts expect the company to announce earnings of $0.40 per share and revenue of $1.2526 billion for the quarter.

ConvaTec Group Price Performance

Shares of CNVVY stock opened at $12.33 on Monday. The stock has a 50 day moving average price of $12.72 and a 200 day moving average price of $12.71. ConvaTec Group has a 52-week low of $11.28 and a 52-week high of $16.65.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Sanford C. Bernstein raised shares of ConvaTec Group to a “strong-buy” rating in a research note on Wednesday, January 28th. Peel Hunt upgraded ConvaTec Group from a “moderate buy” rating to a “strong-buy” rating in a research note on Tuesday, October 28th. Two research analysts have rated the stock with a Strong Buy rating, According to MarketBeat.com, the company has a consensus rating of “Strong Buy”.

ConvaTec Group Company Profile

ConvaTec Group is a global medical products and technologies company focused on developing therapies and technologies for the management of chronic health conditions. The company’s portfolio spans four core business areas—Advanced Wound Care, Ostomy Care, Continence & Critical Care, and Infusion Devices—which are designed to improve patient outcomes and enhance quality of life for people living with long-term health challenges. ConvaTec’s product range includes proprietary wound dressings, ostomy and continence management systems, and safety-engineered infusion sets.

Headquartered in Reading, United Kingdom, ConvaTec serves customers in over 100 countries through a network of manufacturing, distribution, and customer support operations.